ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Formative work to understand factors affecting future TB vaccines acceptanceFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Health system readiness, Health system readinessRead More
Innovative financing for TB vaccine R&DFriday, August 9, 2024Accessibility, FInancing strategies, Policy and frameworksRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in the U.S.Friday, August 9, 2024Availability, Epidemiological impactRead More
TB case-finding in the context of future vaccinesFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: A scoping reviewFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Implementation strategies and feasibility, Implementation strategies and feasibilityRead More
Modelling impact of TB vaccination vs other interventions/policiesFriday, August 9, 2024Availability, Epidemiological impactRead More